Mr. Michal Kovac, ambassador of the Slovak Republic led Mr. Henrich Hercegu, CEO of Chirana group, medical device maker in Slovak and Mr. Hubert Lo, chairman of Zodic Light World Technology, Chirana’s cooperative partner in Taiwan to visit MIRDC at Kaohsiung Science Park on January 22, 2014. Mr. Michal Kovac witnessed the MOU signing between MIRDC and Chirana Group and realized the relative measures for Chirana Group to set up R&D center at Kaohsiung Science Park.
Chirana Group is internationally well-known medical device company and its medical related products and equipment are adopted by international hospitals and clinics in more than 50 countries. Additionally, Chirana Group is equipped with traditional radiology and radiotherapy technologies for more than 70 years. Chirana is a group that is possessed of top core technologies and R&D capabilities. Being its cooperative partner, Zodic Light World Technology also has excellent R&D technology of medical device material in nano scale.
Dr. Ho-chung Fu, president of MIRDC pointed out that MOU signing between Chirana Group and MIRDC hopes non-sticking minimally invasive surgery-metallic ceramic deposition technology of MIRDC could be introduced into Chirana’s new minimally medical device. The technology facilitates the surface of surgical device to be equipped with non-sticking effect through chromium carbide semi-ceramic conductive deposition. The deposition technology could decrease the tissue sticking during operation, reduces the damage of wounds and speeds up healing of wounds after operation.
The semi-ceramic conductive deposition is jointly developed by National Defense University, E-Da Hospital and MIRDC under the project of ”Rapid Prototyping Service Center for Class II and above Medical Device”, sponsored by Department of Industrial Technology, MOEA. Traditional chromium carbide semi-ceramic conductive deposition is completed by vacuum process. Currently this technology has been approved by ISO ISO 10993 Biological Evaluation of Medical Devices and carried out animal experiment by E-Da Hospital.
Dr. Fu indicated that MOU signing between internationally well-known Chirana and MIRDC has proved a successful case for Taiwan to promote the medical device industry as well as Medical Device Special Zone at Kaohsiung. In the future, Chirana Group will set up its R&D center at Kaohsiung Science Park. The R&D center will cultivate a large number of R&D talents, increase the level of medical device industry in southern Taiwan and symbolizes southern Taiwan industry and technologies move forward a big step.